From the Departments of Radiology (D.T.G., R.A.D.L.).
Neurosurgery (D.B., B.Y., K.Y., S.M., C.P.K., R.A.D.L.), Icahn School of Medicine at Mount Sinai (A.M.), New York, New York.
AJNR Am J Neuroradiol. 2021 Jan;42(2):313-318. doi: 10.3174/ajnr.A6971. Epub 2021 Jan 14.
In recent years, the transradial approach has become more widely adopted for neuroendovascular procedures. The purpose of this study was to evaluate the safety and feasibility of a transradial approach and distal transradial access for neuroendovascular procedures in a single center.
Retrospective analysis was performed for all patients who underwent transradial approach or distal transradial access neuroendovascular procedures from January 2016 to August 2019 at a single center. Exclusion criteria included a Barbeau D waveform, a radial artery of <2 mm on sonographic evaluation, and known radial artery occlusion. Procedures were evaluated for technical success (defined as successful radial artery access and completion of the intended procedure without crossover to an auxiliary access site), complications, and adverse events during follow-up at 30 days.
The transradial approach or distal transradial access was attempted in 279 consecutive patients (58.1% women; median age, 57.7 years) who underwent 328 standard or distal transradial approach procedures. Two-hundred seventy-nine transradial approach and 49 distal transradial approach procedures were performed (cerebral angiography [ = 213], intracranial intervention [ = 64], head and neck intervention [ = 30], and stroke intervention [ = 21]). Technical success was 92.1%. Immediate adverse events (2.1%) included radial access site hematoma ( = 5), radial artery occlusion ( = 1), and acute severe radial artery spasm ( = 1). Thirty-day adverse events (0.3%) included a radial artery pseudoaneurysm ( = 1). Twenty-six cases (7.9%) required crossover to transfemoral access.
The transradial approach for neuroendovascular procedures is safe and feasible across a wide range of neuroendovascular interventions.
近年来,经桡动脉入路在神经血管介入中得到了更广泛的应用。本研究旨在评估单一中心经桡动脉入路和远端桡动脉入路在神经血管介入中的安全性和可行性。
回顾性分析了 2016 年 1 月至 2019 年 8 月在单一中心接受经桡动脉入路或远端桡动脉入路神经血管介入治疗的所有患者。排除标准包括 Barbeau D 波型、超声评估桡动脉 <2 mm 和已知桡动脉闭塞。评估手术技术成功率(定义为成功桡动脉入路和完成预期手术而无需交叉至辅助入路)、并发症和 30 天随访期间的不良事件。
279 例连续患者(58.1%女性;中位年龄 57.7 岁)尝试了经桡动脉入路或远端桡动脉入路,共进行了 328 例标准或远端桡动脉入路手术。共进行了 279 例经桡动脉入路和 49 例远端桡动脉入路手术(脑血管造影 = 213 例,颅内介入 = 64 例,头颈部介入 = 30 例,卒中干预 = 21 例)。技术成功率为 92.1%。即刻不良事件(2.1%)包括桡动脉入路部位血肿( = 5 例)、桡动脉闭塞( = 1 例)和急性严重桡动脉痉挛( = 1 例)。30 天不良事件(0.3%)包括桡动脉假性动脉瘤( = 1 例)。26 例(7.9%)需要交叉至股动脉入路。
经桡动脉入路用于神经血管介入治疗是安全可行的,适用于广泛的神经血管介入治疗。